NFA
PETX

Nationwide Fund Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Nationwide Fund Advisors’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-78,383
Closed -$480K – 2801
2017
Q3 		$480K Hold
78,383
– – ﹤0.01% 2209
2017
Q2 		$567K Buy
78,383
+26,130
+50% +$161K ﹤0.01% 2114
2017
Q1 		$277K Sell
52,253
-1,435
-3% -$9.69K ﹤0.01% 2452
2016
Q4 		$385K Sell
53,688
-10,763
-17% -$87K ﹤0.01% 2318
2016
Q3 		$603K Buy
64,451
+12,705
+25% +$106K ﹤0.01% 2082
2016
Q2 		$327K Hold
51,746
– – ﹤0.01% 2371
2016
Q1 		$286K Hold
51,746
– – ﹤0.01% 2368
2015
Q4 		$289K Buy
51,746
+802
+2% +$5.3K ﹤0.01% 2373
2015
Q3 		$431K Buy
50,944
+31,348
+160% +$531K ﹤0.01% 2201
2015
Q2 		$296K Sell
19,596
-1,531
-7% -$22.1K ﹤0.01% 2509
2015
Q1 		$338K Sell
21,127
-536
-2% -$9.54K ﹤0.01% 2445
2014
Q4 		$386K Buy
21,663
+1,804
+9% +$22.5K ﹤0.01% 2335
2014
Q3 		$199K Buy
19,859
+1,335
+7% +$16.2K ﹤0.01% 2692
2014
Q2 		$289K Buy
18,524
+12,497
+207% +$177K ﹤0.01% 2549
2014
Q1 		$112K Buy
6,027
+973
+19% +$19.5K ﹤0.01% 2717
2013
Q4 		$97K Buy
5,054
+3,146
+165% +$63.9K ﹤0.01% 2961
2013
Q3 		$31K Buy
+1,908
New +$20.1K ﹤0.01% 3072

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Nationwide Fund Advisors's PETX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2017, closing a stake of 78,383 shares — an estimated $480K sold.

Nationwide Fund Advisors first reported a position in PETX in Q3 2013 and held it in 17 quarters. The position peaked at $603K in Q3 2016. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 78,383 Aratana Therapeutics, Inc. shares in Q4 2017, an estimated $480K.
  • Nationwide Fund Advisors first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Aratana Therapeutics, Inc. position peaked at $603K in Q3 2016.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.